Congenital anosmia
Congenital anosmia is read (interpretation) as two disjoint R19 failure modes: a CNG channelopathy where the transduction switch cannot flip, and Kallmann organ-formation where the apparatus never clears its presence threshold. Both are direction-only; reported CNGB1 disease affecting smell and rod vision is consistent with the reading.
Two disjoint R19 failure modes: CNG channelopathy (deleting the cubic destroys the flip; ≈229× shallower at the §2 step sizes, a step-dependent code output) and Kallmann organ-formation (the Organ never clears its presence threshold). Reading CNGB1 loss as impairing both smell and rod vision is interpretation, consistent with reported olfactory dysfunction in CNGB1 retinitis pigmentosa. Direction-only, non-clinical.
Failure mode 1 — channelopathy: the transduction switch cannot flip
The olfactory CNG channel is the inherited R19 transduction switch. In a loss-of-function the bistable switch is gone (the cubic struck out), so there is no on-basin and the flip can never occur at any drive — no transduction, no smell. This re-points the cubic's necessity (§2) as the failure.
| gene | γ | h* = spinodal | WT s @ 1.10 h* | LOF (no switch) @ 1.10 h* |
|---|---|---|---|---|
| CNGA2 | 1.2935 | 0.56624 | +1.3276 | +0.4815 |
| CNGB1 | 1.4357 | 0.66213 | +1.3987 | +0.5073 |
Losing the switch costs the all-or-none flip entirely: the wild-type slope ≈ 177 collapses to ≈ 0.77 (a factor ≈ 229× at the §2 step sizes; ≈ 48× or ≈ 24× at other steps — step-dependent code output). The direction-only lever is to re-enable a flip reachable by physiological drive (sign +). No dose, molecule, or efficacy is stated.
Failure mode 2 — organ-formation (Kallmann): the apparatus never emerges
Here the smelling apparatus never forms: the master switch never clears its R19 presence threshold, so the organ is absent ("parts present ≠ trait"). The signature is anosmia with hypogonadotropic hypogonadism — the shared olfactory-placode/GnRH programme failing together.
| gene | γ | h* = spinodal | LOF: present @ 0.90 h* | WT: present @ 1.10 h* |
|---|---|---|---|---|
| ANOS1 | 1.4798 | 0.69287 | absent | present |
| FGFR1 | 1.4785 | 0.69196 | absent | present |
| PROK2 | 1.4634 | 0.68139 | absent | present |
| PROKR2 | 1.4781 | 0.69168 | absent | present |
Code output that follows from the chosen inputs: the LOF column evaluates each master switch at 0.90·h* and the WT column at 1.10·h*, so "absent" and "present" follow from placing the drive below or above the threshold — a demonstration of the mechanism, not a test against patient data. That these four genes cause Kallmann syndrome (anosmia with hypogonadotropic hypogonadism) is an observation.
The direction-only lever is to restore the master switch's clearing of its presence threshold (sign +). The absolute magnitude and developmental window are an [O] this volume does not supply.
Cross-sense and the firewall in action
Because CNGB1 (γ = 1.4357, h* = 0.66213) is the same gene in both senses, a CNGB1 loss-of-function is predicted to fail in two senses at once — olfaction and rod-mediated dim-light vision — read here as one shared R19 switch (interpretation). The combined phenotype is already reported (CNGB1 retinitis pigmentosa with olfactory dysfunction; Charbel Issa et al. 2018), so this is consistency with an observation, not a new prediction.
Every statement here is direction-only: it gives only the failure-mode class (which R19 primitive fails) and the sign of a hypothetical restorative lever. No diagnosis, dose, molecule, or efficacy; the odorant key stays [O]; the felt experience of anosmia is the mind volume's.